Vanta Bioscience

Chennai, India Founded: 2010 • Age: 16 yrs Acquired By Aragen
GLP-certified preclinical contract research services are provided.
Request Access

About Vanta Bioscience

Vanta Bioscience is a company based in Chennai (India) founded in 2010 was acquired by Aragen in November 2014.. The company has 43 employees as of March 22, 2024. Vanta Bioscience offers products and services including Discovery Toxicology, Agro-chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Test. Vanta Bioscience operates in a competitive market with competitors including Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others.

  • Headquarter Chennai, India
  • Employees 43 as on 22 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Vanta Bioscience Ltd.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $229.44 K (USD)
    -79.8
    as on Mar 31, 2024
  • Net Profit
    $-557.83 K (USD)
    -106.18
    as on Mar 31, 2024
  • EBITDA
    $-497.2 K (USD)
    -419.5
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    43

    as on Mar 22, 2024

  • Acquired by
    Aragen

    (Nov 06, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Vanta Bioscience

Vanta Bioscience is a publicly listed company on the BSE with ticker symbol VANTABIO in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: BSE · Ticker: VANTABIO . Sector: Health technology · India

Products & Services of Vanta Bioscience

Vanta Bioscience offers a comprehensive portfolio of products and services, including Discovery Toxicology, Agro-chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Preclinical testing for drug safety and toxicity evaluation

Evaluation of safety for agrochemical products

Assessment of material compatibility for medical devices

Development of specialized diets for research studies

Testing for batch quality in pharmaceutical products

People of Vanta Bioscience
Headcount 50-200
Employee Profiles 1
Employee Profiles
People
Dopesh Mulakala
Managing Director

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Vanta Bioscience

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Vanta Bioscience

Vanta Bioscience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aragen Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Aragen Life Sciences is engaged in contract research and manufacturing for pharmaceuticals.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Vanta Bioscience

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Vanta Bioscience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Vanta Bioscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Vanta Bioscience

Vanta Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
In-vitro and in-vivo genetic toxicology screening services are provided.
domain founded_year HQ Location
Drug development and preclinical services are provided by Tigermed.
domain founded_year HQ Location
Diversified preclinical services for brain-related disorders are provided.
domain founded_year HQ Location
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided.
domain founded_year HQ Location
Contract research on infectious disease models is conducted.
domain founded_year HQ Location
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Vanta Bioscience

Frequently Asked Questions about Vanta Bioscience

When was Vanta Bioscience founded?

Vanta Bioscience was founded in 2010.

Where is Vanta Bioscience located?

Vanta Bioscience is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

How many employees does Vanta Bioscience have?

As of Mar 22, 2024, the latest employee count at Vanta Bioscience is 43.

What is the annual revenue of Vanta Bioscience?

Annual revenue of Vanta Bioscience is $229.44K as on Mar 31, 2024.

What does Vanta Bioscience do?

Vanta Bioscience was founded in 2010 in Chennai, India. Preclinical contract research services, certified under GLP standards, are offered to pharmaceutical, biotech, medical device, cosmetics, and chemical industries. Toxicology studies, biocompatibility assessments, and diet formulation services are included. A state-of-the-art research facility is maintained in compliance with international guidelines for animal care and use, with relevant accreditations ensuring adherence to regulatory requirements.

Who are the top competitors of Vanta Bioscience?

Vanta Bioscience's top competitors include PHAXIAM, Gubra and BioQual.

What products or services does Vanta Bioscience offer?

Vanta Bioscience offers Discovery Toxicology, Agro-chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Test.

Is Vanta Bioscience publicly traded?

Yes, Vanta Bioscience is publicly traded on BSE under the ticker symbol VANTABIO.

Who are Vanta Bioscience's investors?

Vanta Bioscience has 1 investor. Key investors include Aragen Life Sciences.

What is Vanta Bioscience's ticker symbol?

The ticker symbol of Vanta Bioscience is VANTABIO on BSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available